Literature DB >> 21889663

Golimumab for uveitis.

Miguel Cordero-Coma, David Salom, Manuel Díaz-Llopis, María J López-Prats, Sara Calleja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21889663     DOI： 10.1016/j.ophtha.2011.05.019

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  21 in total

Review 1.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

Review 2.  The Use of Biologic Therapies in Uveitis.

Authors:  Sergio Schwartzman; Monica Schwartzman
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

3.  Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab.

Authors:  Sofia Lanz; Gerald Seidel; Andrea Skrabl-Baumgartner
Journal:  Pediatr Rheumatol Online J       Date:  2021-08-21       Impact factor: 3.054

Review 4.  Treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  Rosa Bou; Estíbaliz Iglesias; Jordi Antón
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 5.  Pharmacotherapy of scleritis: current paradigms and future directions.

Authors:  Robert M Beardsley; Eric B Suhler; James T Rosenbaum; Phoebe Lin
Journal:  Expert Opin Pharmacother       Date:  2013-02-21       Impact factor: 3.889

Review 6.  Pediatric uveitis: new and future treatments.

Authors:  Preema J Mehta; Janet L Alexander; H Nida Sen
Journal:  Curr Opin Ophthalmol       Date:  2013-09       Impact factor: 3.761

Review 7.  Non-Infectious Uveitis: Optimising the Therapeutic Response.

Authors:  Archana Airody; Greg Heath; Susan Lightman; Richard Gale
Journal:  Drugs       Date:  2016-01       Impact factor: 9.546

Review 8.  Current and future treatments for Behçet's uveitis: road to remission.

Authors:  Marina Mesquida; Blanca Molins; Victor Llorenç; María Victoria Hernández; Gerard Espinosa; Andrew D Dick; Alfredo Adán
Journal:  Int Ophthalmol       Date:  2013-06-01       Impact factor: 2.031

9.  Clinical use of biologics in vasculitis syndromes.

Authors:  Marino Paroli
Journal:  Biologics       Date:  2012-10-25

10.  Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis.

Authors:  Mridula William; Sepideh Faez; George N Papaliodis; Ann-Marie Lobo
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.